Seagen Inc.
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Seagen Inc., covering 2018-10-16 to 2018-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma [Phase 2]